| Year | Title | Author(s) |
| 2023 |
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface
Cancers |
Massudi, H Luo, JS Holien, JK Gadde, S Krishan, S Herath, M Koach, J Stevenson, BW Gorman, MA Venkat, P Mayoh, C Luo, XQ Parker, MW Cheung, BB Marshall, GM |
| 2021 |
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
Nature Communications |
Nagy, Z Seneviratne, JA Kanikevich, M Chang, W Mayoh, C Venkat, P Du, YH Jiang, CZ Salib, A Koach, J Carter, DR Mittra, R Liu, T Parker, MW Cheung, BB Marshall, GM |